ISIN | CH0004015290 |
---|---|
Valor Number | 401529 |
Bloomberg Global ID | BBG000C49KN8 |
Fund Name | SYNCHRONY MARKET FUNDS - Synchrony Swiss Equity A |
Fund Provider |
Banque Cantonale de Genève
Genève, Switzerland Phone: +41 58 211 21 11 E-Mail: info@bcge.ch Web: www.bcge.ch |
Fund Provider | Banque Cantonale de Genève |
Representative in Switzerland | |
Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The objective of the Synchrony Swiss Equity Subfund is long term capital growth by investing in shares of the Swiss companies that make up the SPI® index. Companies are identified and selected based on their fundamentals, using a systematic stock-picking methodology. The Subfund invests at least two-thirds of its assets in shares and other securities or participation rights of companies domiciled or having a predominant amount of their business activity in Switzerland, and which are part of the SPI® index. |
Peculiarities |
Current Price * | 106.37 CHF | 01.04.2025 |
---|---|---|
Previous Price * | 105.74 CHF | 31.03.2025 |
52 Week High * | 110.21 CHF | 03.03.2025 |
52 Week Low * | 97.88 CHF | 16.04.2024 |
NAV * | 106.37 CHF | 01.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 205,586,501 | |
Unit/Share Assets *** | 57,398,393 | |
Trading Information SIX |
YTD Performance | +6.39% |
31.12.2024 - 01.04.2025
31.12.2024 01.04.2025 |
---|---|---|
1 month | -3.48% |
03.03.2025 - 01.04.2025
03.03.2025 01.04.2025 |
3 months | +6.18% |
03.01.2025 - 01.04.2025
03.01.2025 01.04.2025 |
6 months | +1.17% |
01.10.2024 - 01.04.2025
01.10.2024 01.04.2025 |
1 year | +5.90% |
02.04.2024 - 01.04.2025
02.04.2024 01.04.2025 |
2 years | +10.87% |
03.04.2023 - 01.04.2025
03.04.2023 01.04.2025 |
3 years | +1.85% |
01.04.2022 - 01.04.2025
01.04.2022 01.04.2025 |
5 years | +39.52% |
01.04.2020 - 01.04.2025
01.04.2020 01.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 10.99% | |
---|---|---|
Novartis AG Registered Shares | 9.84% | |
Roche Holding AG | 9.64% | |
ABB Ltd | 6.40% | |
UBS Group AG | 6.29% | |
Zurich Insurance Group AG | 5.34% | |
Sika AG | 3.64% | |
Lonza Group Ltd | 3.54% | |
Alcon Inc | 3.32% | |
Givaudan SA | 3.30% | |
Last data update | 30.11.2024 |
TER | 0.76% |
---|---|
TER date | 15.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |